Position in INVA
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$21,157,960
+$4,169,100 QoQ
Shares Held
908,067
+6.8% QoQ
Ownership
1.23%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 93.06504916487441.ToString("F0")%
Shared 0.ToString("F0")%
None 6.934950835125601.ToString("F0")%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Derivatives in INVA
reported options exposure · as of Dec 31, 2024CallValue
$428,545
CallShares
24,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $2,976,719,496 across 248 Biotechnology names. INVA ranks #22 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,537,736 | $686,660,626 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
625,388 | $483,199,777 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
761,464 | $251,945,590 | |
| 4 | INCY |
Incyte Corp
|
1,264,195 | $118,986,027 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,453,303 | $117,684,942 | |
| 6 | ARGX |
Argenx SE
|
139,381 | $101,782,972 | |
| 7 | INSM |
INSMED Inc
|
562,474 | $91,975,745 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
306,111 | $61,115,059 |
All Filings in INVA
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,157,960 | 908,067 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $16,988,860 | 849,868 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $17,908,469 | 981,286 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $21,870,294 | 1,088,616 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $15,006,743 | 827,730 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $428,545 | 24,700 | Call | Sole | 2025-06-30 | |
| 2024-12-31 | $14,566,747 | 839,582 | Shares | Sole | 2025-06-30 | |
| 2024-09-30 | $482,750 | 25,000 | Call | Sole | 2025-06-26 | |
| 2024-09-30 | $16,377,891 | 848,156 | Shares | Sole | 2025-06-26 | |
| 2024-06-30 | $12,290,848 | 749,442 | Shares | Sole | 2025-06-12 | |
| 2024-03-31 | $393,192 | 25,800 | Call | Sole | 2025-06-02 | |
| 2024-03-31 | $10,812,839 | 709,504 | Shares | Sole | 2025-06-02 | |
| 2023-12-31 | $11,540,858 | 719,505 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $1,815,728 | 113,200 | Call | Sole | 2024-02-14 | |
| 2023-09-30 | $8,268,873 | 636,557 | Shares | Sole | 2023-11-24 | |
| 2023-09-30 | $324,750 | 25,000 | Call | Sole | 2023-11-24 | |
| 2023-06-30 | $8,179,278 | 642,520 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,798,306 | 604,294 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $8,107,741 | 611,905 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $6,825,216 | 587,874 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,352,372 | 565,879 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $2,090,360 | 108,029 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,383,414 | 196,140 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $8,184,256 | 489,782 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $6,946,217 | 517,988 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $13,458,757 | 1,126,256 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $10,482,459 | 846,042 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $10,957,031 | 1,048,520 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,975,595 | 141,316 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $4,875,929 | 414,620 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||